📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MeiraGTx

1.1 - Company Overview

MeiraGTx Logo

MeiraGTx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of AAV-based gene therapies for inherited and acquired disorders, including programs for X-linked retinitis pigmentosa (RPGR), RPE65-associated retinal dystrophy, achromatopsia (CNGB3 and CNGA3), radiation-induced xerostomia (AAV2-hAQP1), and Parkinson’s disease (AAV-GAD).

Products and services

  • AAV2-hAQP1 for Radiation-Induced Xerostomia: AAV2 vector gene therapy that elevates saliva secretion by enhancing water flow across salivary gland cells to alleviate radiation-induced dry mouth in head and neck cancer
  • AAV-CNGA3 for Achromatopsia: AAV-based gene product delivering a functional CNGA3 to the retina to restore cone photoreceptor activity in achromatopsia caused by CNGA3 mutations
  • AAV-CNGB3 for Achromatopsia: AAV-based gene therapy engineered to deliver functional CNGB3 to retinal cells, restoring cone photoreceptor function in patients with achromatopsia due to CNGB3 gene mutations

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MeiraGTx

Helix Logo

Helix

HQ: United States Website
  • Description: Provider of population genomics solutions to advance research and integrate genomic data into clinical care, offering Exome+® sequencing; an integrated platform to collect, sequence, interpret, store, and share genetic information with a DNA product marketplace; Helix Insights; population genomics programs; diagnostic testing for hereditary cancer, cardiovascular disorders, pharmacogenomics, and proactive screening; and large-scale research programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Helix company profile →
Select Immunogenomics Logo

Select Immunogenomics

HQ: United States Website
  • Description: Provider of data analysis, predictive modeling, and reporting in support of genomic studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Select Immunogenomics company profile →
Redpin Therapeutics Logo

Redpin Therapeutics

HQ: United States Website
  • Description: Provider of a preclinical-stage gene therapy platform developing proprietary chemogenetics for targeted cell therapies to address currently intractable diseases of the nervous system, integrating principles from synthetic biology, gene therapy, and traditional pharmacotherapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Redpin Therapeutics company profile →
Axenis Logo

Axenis

HQ: France Website
  • Description: Provider of humanized mouse models as preclinical tools in immunology for the pharmaceutical industry, biotechnology companies, and academic research, using new immunocompromised mouse strains permissive to human tissue xenograft transplantation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axenis company profile →
Tavec Pharma Logo

Tavec Pharma

HQ: Canada Website
  • Description: Provider of injectable cancer therapies using exosome-mediated delivery technology. The company enables delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tavec Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MeiraGTx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MeiraGTx

2.2 - Growth funds investing in similar companies to MeiraGTx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MeiraGTx

4.2 - Public trading comparable groups for MeiraGTx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MeiraGTx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MeiraGTx

What does MeiraGTx do?

MeiraGTx is a provider of AAV-based gene therapies for inherited and acquired disorders, including programs for X-linked retinitis pigmentosa (RPGR), RPE65-associated retinal dystrophy, achromatopsia (CNGB3 and CNGA3), radiation-induced xerostomia (AAV2-hAQP1), and Parkinson’s disease (AAV-GAD).

Who are MeiraGTx's competitors?

MeiraGTx's competitors and similar companies include Helix, Select Immunogenomics, Redpin Therapeutics, Axenis, and Tavec Pharma.

Where is MeiraGTx headquartered?

MeiraGTx is headquartered in United States.

How many employees does MeiraGTx have?

MeiraGTx has 1,000 employees 🔒.

When was MeiraGTx founded?

MeiraGTx was founded in 2010 🔒.

What sector and industry vertical is MeiraGTx in?

MeiraGTx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MeiraGTx

Who are the top strategic acquirers in MeiraGTx's sector and industry

Top strategic M&A buyers and acquirers in MeiraGTx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MeiraGTx?

Top strategic M&A buyers groups and sectors for MeiraGTx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MeiraGTx's sector and industry vertical

Which are the top PE firms investing in MeiraGTx's sector and industry vertical?

Top PE firms investing in MeiraGTx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MeiraGTx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MeiraGTx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MeiraGTx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MeiraGTx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MeiraGTx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MeiraGTx?

The key public trading comparables and valuation benchmarks for MeiraGTx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MeiraGTx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MeiraGTx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MeiraGTx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MeiraGTx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MeiraGTx's' sector and industry vertical?

Access recent funding rounds and capital raises in MeiraGTx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MeiraGTx